PMC Group International Announces Acquisition of Copperhead Chemical Company
전체 맥락을 이해하기 위해서는 본문 보기를 권장합니다.
"The acquisition of Copperhead and its associated companies increases our penetration of the pharma market," said Dr. Raj Chakrabarti, President of PMC Group International. According to Dr. Chakrabarti "this new acquisition will fit neatly and synergistically with our other Pharmaceutical services and manufacturing companies - especially PMC Isochem in France with three sites that include manufacturing of excipients and APIs as well as protein engineering, drug development and drug discovery services; and PMC YM-Pharma in Hyderabad, India, which provides process development and advanced pharmaceutical intermediate manufacturing services." Dr. Raj Chakrabarti added that Copperhead will also have further manufacturing and marketing synergies with PMC Ouvrie, which is a leading supplier of defoamers, surfactants, and protective colloids for food and other industrial applications. He further added that "with the acquisition of Copperhead, PMC Group International is now poised to provide an end-to-end CDMO offering spanning all phases of drug development and manufacturing across three continents."
이 뉴스는 기업·기관·단체가 뉴스와이어를 통해 배포한 보도자료입니다.
이 글자크기로 변경됩니다.
(예시) 가장 빠른 뉴스가 있고 다양한 정보, 쌍방향 소통이 숨쉬는 다음뉴스를 만나보세요. 다음뉴스는 국내외 주요이슈와 실시간 속보, 문화생활 및 다양한 분야의 뉴스를 입체적으로 전달하고 있습니다.
MOUNT LAUREL, N.J. -- Businesswire -- PMC Group International, Inc., which is an independent arm of PMC Group Companies, announced the acquisition of Cobra Investments Management Inc. and its two subsidiaries, Copperhead Chemical Company Inc. (“Copperhead”) and Copperhead Investments Inc., from a group of previous owners of these entities, effective February 5, 2021. Copperhead is the manufacturing arm of the three acquired entities and is located on an 875 acres facility with 53 buildings in Tamaqua, Pennsylvania.
Copperhead has been the sole manufacturer of the FDA approved cardiac therapeutic drug nitroglycerin in the US for over 70 years and a custom manufacturer of drug dosage forms. It is also a major producer of energetic chemicals (explosives and propellants) for the defense industry as well as a novel class of preservatives and antimicrobials. Copperhead’s products are sold globally.
“The acquisition of Copperhead and its associated companies increases our penetration of the pharma market,” said Dr. Raj Chakrabarti, President of PMC Group International. According to Dr. Chakrabarti “this new acquisition will fit neatly and synergistically with our other Pharmaceutical services and manufacturing companies - especially PMC Isochem in France with three sites that include manufacturing of excipients and APIs as well as protein engineering, drug development and drug discovery services; and PMC YM-Pharma in Hyderabad, India, which provides process development and advanced pharmaceutical intermediate manufacturing services.” Dr. Raj Chakrabarti added that Copperhead will also have further manufacturing and marketing synergies with PMC Ouvrie, which is a leading supplier of defoamers, surfactants, and protective colloids for food and other industrial applications. He further added that “with the acquisition of Copperhead, PMC Group International is now poised to provide an end-to-end CDMO offering spanning all phases of drug development and manufacturing across three continents.”
ABOUT PMC Group Companies:
PMC Group is a US based growth oriented, diversified, global chemicals and pharmaceuticals company dedicated to innovative solutions to every need in a broad range of end markets including, plastics, consumer products, electronics, coatings, packaging, mining, personal care, food, automotive and pharmaceuticals. The Company was built on a sustainable model of growth through innovation while promoting social good. PMC operates from a global manufacturing, innovation, and marketing platform with facilities in the Americas, Europe, and Asia. More information about PMC Group and its activities around the world can be found at www.pmc-group.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210222005953/en/
이 뉴스는 기업·기관·단체가 뉴스와이어를 통해 배포한 보도자료입니다.
출처:PMC Group International, Inc.
보도자료 통신사 뉴스와이어(www.newswire.co.kr) 배포
Copyright © 뉴스와이어. 무단전재 및 재배포 금지.
- 현대자동차, 북미서 수소전기트럭 사업 본격 전개 - 뉴스와이어
- 클린 바디케어 브랜드 데미플로, 첫 전속모델로 배우 ‘이이담’ 발탁 - 뉴스와이어
- 대한항공, 포르투갈 리스본 직항 노선 운항 - 뉴스와이어
- 구조견 ‘줄기세포 치료’로 다리 마비 극복… 반려견 치료 새 장 열리나 - 뉴스와이어
- 팍스젠바이오, 중소벤처기업부 주관 ‘글로벌강소기업 1000+ 프로젝트’ 최종 선정 - 뉴스와이어
- 보쉬 모빌리티 애프터마켓 사업부, 황사와 미세먼지 많은 봄철 내 차에 맞는 에어컨/히터 필터
- TMCA Complex, 메타버스로 모두를 위한 미술관을 꿈꾸다 - 뉴스와이어
- 에덴요양병원, 고속도로 개통으로 접근성 크게 개선 - 뉴스와이어
- 현대자동차그룹, 미국 IIHS 충돌평가 최고 안전한 차 최다 선정 - 뉴스와이어
- 서울그린트러스트, 서울식물원 내 어린이를 위한 열린놀이공간 ‘거인의 정원’ 시즌2 선보여 -